HIV postexposure prophylaxis during COVID-19

Lancet HIV. 2020 Jul;7(7):e460. doi: 10.1016/S2352-3018(20)30146-6. Epub 2020 May 25.

Authors

Muhammad Junejo¹, Nicolo Girometti¹, Alan McOwan¹, Gary Whitlock²; Dean Street Collaborative Group

Collaborators

Dean Street Collaborative Group:
Keerti Gedela, Nicolo Girometti, Sheena McCormack, Alan McOwan, Diarmuid Nugent, Sheel Patel, Tara Suchak, Victoria Tittle, Gary Whitlock

Affiliations

¹ 56 Dean Street, Chelsea and Westminster Hospital National Health Service Foundation Trust, London W1D 6AQ, UK.
² 56 Dean Street, Chelsea and Westminster Hospital National Health Service Foundation Trust, London W1D 6AQ, UK. Electronic address: gary.whitlock@chelwest.nhs.uk.

No abstract available

Publication types

Letter

MeSH terms

Adult
Anti-HIV Agents / therapeutic use*
Betacoronavirus / pathogenicity*
COVID-19 / epidemiology*
COVID-19 / prevention & control
COVID-19 / psychology
COVID-19 / transmission
Coinfection
Coronavirus Infections / epidemiology*
Coronavirus Infections / prevention & control
Coronavirus Infections / psychology
Coronavirus Infections / transmission
Drug Prescriptions / statistics & numerical data
Female
HIV / drug effects
HIV / pathogenicity
HIV Infections / epidemiology*
HIV Infections / prevention & control*
HIV Infections / psychology
HIV Infections / transmission
Humans
Male
Pandemics* / prevention & control
Physical Distancing
Pneumonia, Viral / epidemiology*
Pneumonia, Viral / prevention & control
Pneumonia, Viral / psychology
Pneumonia, Viral / transmission
Post-Exposure Prophylaxis / methods
Post-Exposure Prophylaxis / statistics & numerical data
Prescription Drug Monitoring Programs
SARS-CoV-2
Sexual Partners / psychology
United Kingdom / epidemiology

Substances

Anti-HIV Agents